Sanarus Technologies, LLC is a privately held medical device company committed to providing patients and health care professionals with minimally invasive solutions that improve the quality of life.
Since Sanarus Medical, Inc. was founded in 1999, they have focused on fulfilling this mission by developing safe and effective products for the comprehensive treatment of breast disease.
Through proprietary cryoablation technology, Sanarus offers physicians and patients a comfortable and cost effective alternative to operating room-based, surgically intensive care.
The leader in breast care cryoablation The Sanarus Visica® Treatment System is the first and only system available for the cryoablation of fibroadenomas.
Sanarus is currently working to extend the use of cryoablation into other areas of breast care, including breast cancer, through continuing research and improvement of our diagnostic and treatment technology.